Corealis Pharma will be attending BIO International Convention 2026, taking place June 22–25 in San Diego, California. Members of our leadership team, including CEO David Leroux-Petersen, Annie Staten, and David Kwajewski, will be available throughout the conference to discuss formulation development, analytical services, GMP clinical manufacturing, and strategies for accelerating oral solid dose programs from concept to clinic.

As part of this year's program, David Leroux-Petersen will participate as a panelist at the Networking Breakfast and Panel Discussion, How Can Emerging Biotechs De-Risk and Scale Through Smarter Partnerships?, on Tuesday, June 23, from 7:30 AM to 9:00 AM PDT. The discussion will explore how strategic partnerships can help emerging biotech companies reduce development risk, access specialized expertise, and build scalable pathways toward commercialization.

If you are attending BIO 2026, we invite you to connect with our team and schedule a meeting to discuss your development and manufacturing goals.